Patient Stories

How real patients won back coverage with Claimable

Denice’s Safe Infusion Win

​
Approved in 24 hours after a dangerous site switch and a $1,660 surprise bill
Denial Reason
Out of Network
Denial History
Provider called and emailed 20+ times
Provider called and emailed 20+ times
Denice’s Safe Infusion Win
Approved in 24 hours after a dangerous site switch and a $1,660 surprise bill
6 appeals and requests ignored
Jennifer’s Actemra Approval
After 242 days without treatment, approved with Claimable in just 5 days
Traditional channels exhausted
Reinstating IVIG Coverage
Lifesaving Gammagard therapy approved for a pediatric PANS patient
Provider appeal denied
Tara’s Forced Switch Win
Approved for Zepbound after being told to take an unsafe alternative
See All Stories
Denial: Rheumatoid Arthritis

Claimable helped Jennifer reverse her denial in just 5 days.

It was amazing to actually have somebody on my side that was fighting for me…helping me make my quality of life better.”
Jennifer
Approved for Actemra

In the news

Winning a 9-month fight for cancer care

Stephanie's insurer denied her therapy for 9 months, causing worsening symptoms and delayed cancer treatment.
Watch the story on NBC:
Watch the story

Getting a child's PANS treatment covered

UnitedHealthcare denied Emily's immunoglobulin therapy five times before her family won the appeal that got her treatment approved.
Read the story in the Wall Street Journal:
READ THE STORY

All stories

This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
Strensiq
Sucraid
Infliximab
Zymfentra
Zepbound
Zomig
Zavzpret
Yusimry
Yuflyma
Xopenex HFA
Xolair
Xeljanz
Wegovy
Vyepti
Ubrelvy
Truxima
Tremfya
Tezspire
Taltz
Symbicort
Sub-q immunoglobulin
Stelara
Sotyktu
Skyrizi
Singulair
Simponi Aria
Rybelsus
Simponi
Simlandi
Ruxience
Rituxan
Rinvoq
Riabni
Reyvow
Renflexis
Remicade
Qulipta
Privigen
Panglobulin
Ozempic
Otezla
Orencia
Octagam
Nabi-HB
Nucala
Nurtec
Mounjaro
Krystexxa
Kineret
Kevzara
Ixifi
Inflectra
Imitrex Nasal
Intravenous immunoglobulin
Hyrimoz
Imitrex
Idacio
Hulio
Humira
Hadlima
Gamunex-C
Frova
Fasenra
Gammagard Liquid
Gammagard S/D
Flebogamma DIF
Eticovo
Entyvio
Erelzi
Emgality
Enbrel
Dulera
Dupixent
Cosentyx
Cyltezo
Cinqair
Cimzia
Carimune NF
Bivigam
Breyna
Botox
Breo Ellipta
Axert
Avsola
Aimovig
Ajovy
Amjevita
Actemra
Abrilada
Amerge
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Provider called and emailed 20+ times
Denice’s Safe Infusion Win
Approved in 24 hours after a dangerous site switch and a $1,660 surprise bill
Truxima
6 appeals and requests ignored
Jennifer’s Actemra Approval
After 242 days without treatment, approved with Claimable in just 5 days
Actemra
Traditional channels exhausted
Reinstating IVIG Coverage
Lifesaving Gammagard therapy approved for a pediatric PANS patient
Gammagard Liquid
Provider appeal denied
Tara’s Forced Switch Win
Approved for Zepbound after being told to take an unsafe alternative
Zepbound
Provider appeal unsuccessful
Winning A Formulary Exception
Restoring biologic coverage after a formulary change
Dupixent
Lost 3 prior appeals
Restarting Cancer Care
Overturning a nine-month denial to resume life-saving cancer care
Infliximab
Lost 4 prior appeals
John's Remicade Approval
After a 123-day care gap, approved with Claimable in just 10 days
Remicade

Let's get you covered.

Start My Appeal
Explore
Social